 |
|
|
| |
HBsAg declines observed with VRON-0200 alone are rapidly enhanced with the addition of combination antiviral therapies: results from a Phase 1b study for functional cure in chronically HBV-infected patients
|
| |
| |
AASLD 2025 Nov 7-11 Wash DC
Grace Lai-Hung Wong1, Tien Huey Lim2, Sue Currie3, Andrew Luber3, Marie Bonhomme4, Edward J. Gane5
|
| |
|
|
|
|
|
